User profiles for D. R. Stanski

Donald Stanski

Vice President, AstraZeneca Pharmaceuticals
Verified email at astrazeneca.com
Cited by 16582

Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine

LB Sheiner, DR Stanski, S Vozeh… - Clinical …, 1979 - Wiley Online Library
We propose a model of drug pharmacodynamic response that when integrated with a
pharmacokinetic model allows characterization of the temporal aspects of pharmacodynamics as …

The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.

…, P Fiset, DJ Hermann, KT Muir, DR Stanski… - …, 1993 - europepmc.org
Background Remifentanil (GI87084B) is a new short-acting opioid with a unique ester structure.
Metabolism of remifentanil by ester hydrolysis results in very rapid elimination. The aim …

[PDF][PDF] Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

JC Scott, DR Stanski - Journal of Pharmacology and Experimental …, 1987 - Citeseer
The effect of increasing age on the dose of fentanyl or alfentanil required to produce the
same electroencephalographic(EEG) stage was studied in adult male patients. The …

EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

JC Scott, KV Ponganis, DR Stanski - Anesthesiology, 1985 - europepmc.org
Fentanyl and alfentanil produce very similar electroencephalographic (EEG) changes in
humans. With increasing serum concentrations of either narcotic, progressive slowing in …

Comparative pharmacology of the ketamine isomers: studies in volunteers

…, J Schüttler, A Shafer, DR Stanski… - BJA: British Journal …, 1985 - academic.oup.com
The clinical and electroencephalographic (EEG) effects of the individual ketamine isomers
were compared with the racemic mixture in five volunteers who received each drug on a …

Defining depth of anesthesia

SL Shafer, DR Stanski - Modern anesthetics, 2008 - Springer
In this chapter, drawn largely from the synthesis of material that we first presented in the sixth
edition of Miller’s Anesthesia, Chap 31 (Stanski and Shafer 2005; used by permission of …

Absorption characteristics of transdermally administered fentanyl.

…, SL Shafer, SS Hwang, PA Coen, DR Stanski - …, 1989 - europepmc.org
Fentanyl was administered intravenously and transdermally to eight surgical patients to
determine the systemic bioavailability and rate of absorption of the transdermally administered …

Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil.

JC Scott, JE Cooke, DR Stanski - Anesthesiology, 1991 - europepmc.org
The authors compared the pharmacodynamics of sufentanil with those of fentanyl using the
electroencephalogram (EEG) as a measure of opioid drug effect. Sixteen patients were given …

Absorption and bioavailability of oral transmucosal fentanyl citrate.

JB Streisand, JR Varvel, DR Stanski, L Le Maire… - …, 1991 - europepmc.org
Oral transmucosal fentanyl citrate (OTFC) is a novel, noninvasive dosage form of fentanyl
used to provide children and adults with sedation, anxiolysis, and analgesia. In order to …

A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect

…, PL Gambus, N Chamoun, DR Stanski… - Clinical …, 1997 - Wiley Online Library
… Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a
simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987;…